title: In vivo effect of statins on the expression of the HIV co-receptors CCR5 and CXCR4.
abstract: BACKGROUND
  During the HIV-1 replication cycle, several molecules including chemokine receptors and cholesterol are crucial, and are therefore potential targets for therapeutic intervention. Indeed statins, compounds that inhibit cellular synthesis of cholesterol and have anti-inflammatory and immunomodulatory properties were shown to inhibit HIV-1 infection by R5 tropic strains but not by X4 strains in vitro, mainly by altering the chemokine receptor/ligands axes. Therefore, the objective of this study was to characterize in vivo, the capacity of statins to modulate in HIV seronegative and chronically HIV-1-infected adults the expression of CCR5 and CXCR4, of their ligands and the tropism of circulating HIV-1 strains.
  
  
  METHODS
  Samples from asymptomatic HIV-1-infected adults enrolled in a clinical trial aimed at evaluating the antiretroviral activity of lovastatin were used to evaluate in vivo the modulation by lovastatin of CCR5, CXCR4, their ligands, and the shift in plasma viral tropism over one year of intervention. In addition, ten HIV negative adults received a daily oral dose of 40 mg of lovastatin or 20 mg of atorvastatin; seven other HIV negative individuals who received no treatment were followed as controls. The frequency and phenotype of immune cells were determined by flow-cytometry; mRNA levels of chemokine receptors and their ligands were determined by real-time PCR. Viral tropism was determined by PCR and sequencing, applying the clonal and clinical model of analyses.
  
  
  RESULTS
  Our study shows that long-term administration of lovastatin in HIV-infected individuals does not induce a shift in viral tropism, or induce a significant modulation of CCR5 and CXCR4 on immune cells in HIV-infected patients. Similar results were found in HIV seronegative control subjects, treated with lovastatin or atorvastatin, but a significant increase in CCL3 and CCL4 transcription was observed in these individuals.
  
  
  CONCLUSIONS
  These findings suggest that long-term administration of statins at therapeutic doses, does not significantly affect the expression of HIV-1 co-receptors or of their ligands. In addition it is important to point out that based on the results obtained, therapeutic administration of statins in HIV-infected patients with lipid disorders is safe in terms of selecting X4 strains.
authors: Immunovirology Group, School of Medicine, University of Antioquia, Medellin, Colombia.
authors: Edwin A
authors: EA
authors: Higuita
authors: Department of Internal Medicine and Academic Group of Clinical Epidemiology (GRAEPIC), School of Medicine, University of Antioquia, Medellín, Colombia ; Clinical Research Unit, Hospital Pablo Tobón Uribe, Medellin, Colombia.
authors: Fabián A
authors: FA
authors: Jaimes
authors: Immunovirology Group, School of Medicine, University of Antioquia, Medellin, Colombia.
authors: Maria T
authors: MT
authors: Rugeles
authors: Immunovirology Group, School of Medicine, University of Antioquia, Medellin, Colombia.
authors: Carlos J
authors: CJ
authors: Montoya
keywords: CCR5; CXCR4; Chemokines; HIV infection; Statins; Viral tropism
references: Curr Opin HIV AIDS. 2012 Sep;7(5):456-62
references: 22832708
references: J Exp Med. 2006 Feb 20;203(2):401-12
references: 16476765
references: Nat Med. 1996 Nov;2(11):1240-3
references: 8898752
references: Oncol Rep. 2004 Dec;12(6):1371-5
references: 15547765
references: Pancreas. 2012 Nov;41(8):1331-5
references: 22695133
references: Mol Med. 1997 Jan;3(1):23-36
references: 9132277
references: Biochim Biophys Acta. 2002 Dec 23;1567(1-2):157-64
references: 12488049
references: J Biol Chem. 2002 Jun 14;277(24):21776-85
references: 11929877
references: HIV Med. 2011 Oct;12(9):544-52
references: 21518222
references: J Natl Cancer Inst. 2011 May 4;103(9):753-62
references: 21483021
references: PLoS One. 2007 May 23;2(5):e470
references: 17520029
references: J Virol. 2006 Dec;80(24):12425-9
references: 17035326
references: Int J Breast Cancer. 2011;2011:420981
references: 22295222
references: Curr Opin HIV AIDS. 2009 Mar;4(2):96-103
references: 19339947
references: F1000 Med Rep. 2010 Dec 08;2:85
references: 21283597
references: Semin Liver Dis. 2012 May;32(2):167-76
references: 22760656
references: HIV Clin Trials. 2008 Jul-Aug;9(4):225-37
references: 18753117
references: J Exp Med. 2004 Aug 16;200(4):541-7
references: 15314078
references: Virology. 1995 Mar 10;207(2):528-42
references: 7886956
references: Mini Rev Med Chem. 2009 Dec;9(14):1605-21
references: 20088780
references: J Virol. 1998 Mar;72(3):2002-9
references: 9499054
references: Trials. 2009 Jun 18;10:41
references: 19538732
references: J Immunol. 2009 Jan 1;182(1):171-82
references: 19109148
references: HIV Clin Trials. 2012 Jul-Aug;13(4):189-211
references: 22849961
references: Nat Rev Drug Discov. 2003 Jul;2(7):517-26
references: 12815379
references: AIDS. 2011 Jun 19;25(10):1332-3
references: 21508802
references: Clin Exp Immunol. 2006 Dec;146(3):524-32
references: 17100774
references: J Neuroimmune Pharmacol. 2012 Mar;7(1):95-112
references: 21947740
references: Lancet. 1997 Apr 26;349(9060):1219-20
references: 9130946
references: AIDS Rev. 2010 Jul-Sep;12(3):164-76
references: 20842205
references: Science. 1996 Sep 27;273(5283):1856-62
references: 8791590
references: AIDS Res Hum Retroviruses. 2001 Jul 20;17(11):1009-19
references: 11485618
references: Curr HIV Res. 2009 Jul;7(4):418-24
references: 19601777
references: Cancer Res. 1976 Sep;36(9 PT 2):3526-34
references: 975112
references: Soc Sci Med. 2012 May;74(10):1486-93
references: 22459188
references: Virology. 2007 Aug 1;364(2):281-90
references: 17428518
references: Future Microbiol. 2010 Jul;5(7):1025-39
references: 20632803
references: J Immunol. 1998 Oct 1;161(7):3702-10
references: 9759895
references: J Infect. 2004 Nov;49(4):283-90
references: 15474625
references: Enferm Infecc Microbiol Clin. 2008 Jun-Jul;26(6):325-9
references: 18588813
references: N Engl J Med. 2008 Oct 2;359(14):1429-41
references: 18832244
references: Expert Opin Drug Saf. 2012 Jan;11(1):161-74
references: 22118500
references: Virology. 1998 Apr 25;244(1):66-73
references: 9581779
references: Nat Biotechnol. 2007 Dec;25(12):1407-10
references: 18066037
references: Curr Opin HIV AIDS. 2009 Mar;4(2):88-95
references: 19339946
references: Cancer Metastasis Rev. 2010 Dec;29(4):709-22
references: 20839032
references: Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1269-74
references: 10655520
references: J Immunol. 2002 Apr 15;168(8):4121-6
references: 11937572
references: Nat Med. 1997 Mar;3(3):252-3
references: 9055842
references: Br J Pharmacol. 2008 Oct;155(4):444-54
references: 18536743
references: J Immunol. 2005 May 1;174(9):5630-5
references: 15843562
references: J Infect. 2012 Dec;65(6):549-58
references: 23085245
references: Nat Clin Pract Rheumatol. 2008 Aug;4(8):428-38
references: 18577999
references: J Am Coll Cardiol. 1997 Nov 1;30(5):1212-7
references: 9350917
references: PLoS Pathog. 2010 Feb 19;6(2):e1000766
references: 20174557
references: Clin Exp Immunol. 2010 Oct;162(1):41-52
references: 20659124
references: Nat Rev Immunol. 2008 May;8(5):349-61
references: 18437155
references: Stem Cells. 1998;16(2):79-88
references: 9554031
references: J Virol. 2000 Apr;74(7):3264-72
references: 10708443
references: PLoS One. 2012;7(2):e31226
references: 22359577
references: J Biol Chem. 1992 Nov 5;267(31):22686-92
references: 1429616
references: EMBO Rep. 2000 Aug;1(2):190-6
references: 11265761
references: J Virol. 2003 Aug;77(15):8237-48
references: 12857892
references: Clin Lung Cancer. 2012 Jan;13(1):6-13
references: 21802373
references: Nature. 1996 Aug 22;382(6593):722-5
references: 8751444
references: Hum Immunol. 2001 Jul;62(7):668-78
references: 11423172
references: Br J Cancer. 2012 Jun 26;107(1):43-52
references: 22644306
references: Nat Rev Immunol. 2006 May;6(5):358-70
references: 16639429
references: AIDS Res Hum Retroviruses. 2003 Aug;19(8):675-87
references: 13678470
references: Int J Gynecol Pathol. 2012 May;31(3):286-93
references: 22498948
references: Virology. 2009 Mar 30;386(1):23-31
references: 19178925
references: Swiss Med Wkly. 2001 Jan 27;131(3-4):41-6
references: 11219190